🇺🇸 FDA
Patent

US 11623930

Imidazodiazepinediones and methods of use thereof

granted A61PA61P13/12A61P25/00

Quick answer

US patent 11623930 (Imidazodiazepinediones and methods of use thereof) held by Goldfinch Bio, Inc. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Goldfinch Bio, Inc.
Grant date
Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P13/12, A61P25/00, A61P35/00